Shares of Boston Scientific Corporation BSX jumped 6% to reach $18.16 yesterday, following the launch of LithoVue Single-Use Digital Flexible Ureteroscope simultaneously in the U.S. and Europe. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted 510(k) clearance to Boston Scientific ...

Marlborough, Mass. Boston Scientific Corporation today announced the European launch of the LithoVue™ Single-Use Digital Flexible Ureteroscope for minimally invasive endoscopic procedures to diagnose ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Boston Scientific’s LithoVue Elite Single-Use Digital Flexible Ureteroscope System recently obtained FDA 510(k) clearance, becoming the first ureteroscope system with the ability to monitor intrarenal ...

(RTTNews) - Boston Scientific Corp. (BSX) said Friday that it has received a 510(k) clearance from the U.S. Food and Drug Administration for the LithoVue Elite Single-Use Digital Flexible Ureteroscope ...

Credit: Getty Images A pressure sensor at the tip of the ureteroscope provides real-time measurements. The FDA has approved marketing of the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope ...

Boston Scientific Corp. has received clearance from the U.S. Food and Drug Administration for its new device designed to make kidney stone procedures safer and easier. The Marlborough company ...

Boston Scientific CorporationBSX recently launched its new urology device globally. Called LithoVue Empower Retrieval Deployment Device, it will be used together with the LithoVue Single-Use Digital ...

MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use ...